Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial

A. Ballhausen, M. Karthaus, S. Fruehauf, U. Graeven, L. Müller, A.O. König, L.F. von Weikersthal, G. Sommerhäuser, I. Jelas, A.H.S. Alig, A. Kurreck, A. Stahler, E. Goekkurt, S. Held, S. Kasper, K. Heinrich, V. Heinemann, S. Stintzing, T. Trarbach, D.P. Modest

Open source

DOI: 10.1016/j.esmoop.2024.103628
Published: 2024-07
Container: ESMO Open
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2024.103628,
  title = {Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial},
  author = {A. Ballhausen and M. Karthaus and S. Fruehauf and U. Graeven and L. Müller and A.O. König and L.F. von Weikersthal and G. Sommerhäuser and I. Jelas and A.H.S. Alig and A. Kurreck and A. Stahler and E. Goekkurt and S. Held and S. Kasper and K. Heinrich and V. Heinemann and S. Stintzing and T. Trarbach and D.P. Modest},
  year = {2024},
  journal = {ESMO Open},
  doi = {10.1016/j.esmoop.2024.103628},
  url = {https://doi.org/10.1016/j.esmoop.2024.103628}
}

RIS

TY  - JOUR
TI  - Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
AU  - A. Ballhausen
AU  - M. Karthaus
AU  - S. Fruehauf
AU  - U. Graeven
AU  - L. Müller
AU  - A.O. König
AU  - L.F. von Weikersthal
AU  - G. Sommerhäuser
AU  - I. Jelas
AU  - A.H.S. Alig
AU  - A. Kurreck
AU  - A. Stahler
AU  - E. Goekkurt
AU  - S. Held
AU  - S. Kasper
AU  - K. Heinrich
AU  - V. Heinemann
AU  - S. Stintzing
AU  - T. Trarbach
AU  - D.P. Modest
PY  - 2024
JO  - ESMO Open
DO  - 10.1016/j.esmoop.2024.103628
UR  - https://doi.org/10.1016/j.esmoop.2024.103628
ER  -

APA

Ballhausen, A., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., König, A., Weikersthal, L. V., Sommerhäuser, G., Jelas, I., Alig, A., Kurreck, A., Stahler, A., Goekkurt, E., Held, S., Kasper, S., Heinrich, K., Heinemann, V., Stintzing, S., Trarbach, T., & Modest, D. (2024). Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial. ESMO Open. https://doi.org/10.1016/j.esmoop.2024.103628

Source records

crossref · retrieved 2026-09-26T19:16:11.766Z